Andrew Dean
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Vascular Tumors and Angiosarcomas
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment
Papers in
- Oncology 82
- Pancreatic and Hepatic Oncology Research 47
- Colorectal Cancer Treatments and Studies 18
- Cancer Treatment and Pharmacology 16
- PARP inhibition in cancer therapy 14
- Lung Cancer Research Studies 11
-
- Ovarian cancer diagnosis and treatment 19
- Co-authors
- Roland E. KnoblauchTrilok ParekhRobin L. JonesNushmia Z. KhokharKristen N. GanjooMohammed MilhemYoun Choi ParkRobert G. Maki
- Journals
- Journal of Clinical Oncology (38 papers)Annals of Oncology (27 papers)Clinical Colorectal Cancer (3 papers)European Journal of Cancer (2 papers)Molecular Cancer Therapeutics (2 papers)
- Partner nations
- AustraliaUnited StatesSpain
In The Last Decade
Andrew Dean
97 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 1.1k
- Reproductive Medicine 272
- Pulmonary and Respiratory Medicine 694
- Cancer Research 267
- Obstetrics and Gynecology 94
Countries citing papers authored by Andrew Dean
This map shows the geographic impact of Andrew Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Dean more than expected).
Fields of papers citing papers by Andrew Dean
This network shows the impact of papers produced by Andrew Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Dean. The network helps show where Andrew Dean may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Dean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 4 | |
| 4 | Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study Hit paper breakdown → | 2023 | 220 |
| 5 | 2023 | 1 | |
| 6 | 2022 | 16 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 1 | |
| 10 | 2020 | 11 | |
| 11 | 2020 | 1 | |
| 12 | 2019 | 1 | |
| 13 | 2019 | 3 | |
| 14 | 2017 | 2 | |
| 15 | 2017 | 38 | |
| 16 | 2016 | 5 | |
| 17 | Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial Hit paper breakdown → | 2015 | 576 |
| 18 | 2007 | 1 | |
| 19 | 1997 | 17 | |
| 20 | 1991 | 18 |
About Andrew Dean
Andrew Dean is a scholar working on Oncology, Reproductive Medicine, Cancer Research, Biotechnology and Internal Medicine, having authored 104 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (47 papers), Cancer Genomics and Diagnostics (28 papers), Ovarian cancer diagnosis and treatment (19 papers), Colorectal Cancer Treatments and Studies (18 papers), Cancer Treatment and Pharmacology (16 papers), PARP inhibition in cancer therapy (14 papers), Lung Cancer Research Studies (11 papers) and Neuroendocrine Tumor Research Advances (10 papers). The work is most often cited by research in Oncology (1.1k citations), Reproductive Medicine (272 citations), Pulmonary and Respiratory Medicine (694 citations), Cancer Research (267 citations) and Obstetrics and Gynecology (94 citations). Andrew Dean has collaborated with scholars based in Australia, United States and Spain. Frequent co-authors include Roland E. Knoblauch, Trilok Parekh, Robin L. Jones, Nushmia Z. Khokhar, Kristen N. Ganjoo, Mohammed Milhem, Youn Choi Park, Robert G. Maki, Shreyaskumar Patel and Martee L. Hensley. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Colorectal Cancer, European Journal of Cancer and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.